Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Outset Medical, Inc. · Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

235 daysmedian FDA review time
451 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K253412Tablo Hemodialysis System (PN-0008000, PN-0006000U)Outset Medical, Inc.2026-01-261180
K232776Tablo® Hemodialysis System; TabloCart™ with Prefiltration DrOutset Medical, Inc.2024-05-032351
K233335Tablo® Hemodialysis SystemOutset Medical, Inc.2023-12-05673
K223248Tablo® Hemodialysis SystemOutset Medical, Inc.2023-06-212430
K211370Tablo Hemodialysis SystemOutset Medical, Inc.2022-07-294511
K210782Tablo CartridgeOutset Medical, Inc.2021-11-262550
K200741Tablo Hemodialysis SystemOutset Medical, Inc.2020-03-3180
K190793Tablo Hemodialysis System, Tablo CartridgeOutset Medical, Inc.2019-12-122591
K160881Tablo ConsoleOutset Medical, Inc.2016-11-152300

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda